Feb 19 (Reuters) - German biopharmaceutical company BioNTech sued Moderna in Delaware federal court on Thursday, alleging ...

BioNTech SE BNTX has filed a patent infringement lawsuit against Moderna Inc. MRNA, alleging that Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, relies on proprietary technology developed and ...

The world could be only a few years away from a cancer vaccine, according to the couple behind the Pfizer/BioNtech COVID-19 vaccine. "We feel that a cure for cancer or to changing cancer patients' ...

Moderna (MRNA) stock is in focus as BioNTech (BNTX) sues the biotech for allegedly violating patent linked to the rival shot developed with Pfizer (PFE). Read more here.

BioNTech has filed a lawsuit against Moderna in a Delaware federal court over allegations of patent infringement related to ...

BioNTech has filed a lawsuit against Moderna in a Delaware federal court, claiming infringement on a patent related to their COVID-19 vaccine technology. Moderna's vaccine, mNEXSPIKE, allegedly ...

Shares of COVID-19 vaccine makers Pfizer Inc (NYSE:PFE), BioNTech SE ADR (NASDAQ:BNTX) and Moderna Inc (NASDAQ:MRNA) are trading lower Friday following a Washington Post report that Trump ...

Shares of BioNTech on Monday slid by more than 6% in morning trading after the German drugmaker shared a gloomy 2023 sales outlook for its Covid vaccine jointly developed with Pfizer. BioNTech ...

PHILADELPHIA -- Pfizer and BioNTech said Tuesday they have submitted Covid-19 vaccine data on children ages 5 to 11 to the US Food and Drug Administration for initial review, but are not yet seeking ...

BERLIN, Jan 1 (Reuters) - BioNTech (22UAy.DE), opens new tab is working flat out with partner Pfizer (PFE.N), opens new tab to boost production of their COVID-19 vaccine, its founders said, warning ...